Delivery Order SPE2DB20D1100-SPE2DB25FD6V6
- Not listed
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $20,773.97 on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,570.63 on July 14, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $5,590.59 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract is not set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be executed from the contractor's location in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,954.49 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents...
- The Defense Logistics Agency awarded a delivery order valued at $49,728.04 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of May 19, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,890.11 on June 16, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed-price delivery order, which is due for completion on June 17, 2025, was competitively awarded without set-aside designation to support the Medical Supply Chain, a division of the Defense Logistics Agency under the Department of Defense. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 7, 2025, for the supply of Orencia 125 mg/ml syringes valued at $8,772.35 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The contract carries no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for Orencia ClickJect 125 mg/ml with a ceiling value of $9,679.46. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance will be...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6V6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. Orencia (abatacept) is a biologic immunosuppressant medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role in supporting military and veteran healthcare systems through the DLA's global pharmaceutical supply chain, delivering specialty medications and biologics across multiple therapeutic domains to meet federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 7/28/25 |